-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroNOS, a Subsidiary of Beyond Air Inc., Secures FDA Orphan Drug Designation for Glioblastoma Treatment

Reuters·09/08/2025 21:21:11

Please log in to view news